[go: up one dir, main page]

MXPA03005374A - Carbazoles antitumorales. - Google Patents

Carbazoles antitumorales.

Info

Publication number
MXPA03005374A
MXPA03005374A MXPA03005374A MXPA03005374A MXPA03005374A MX PA03005374 A MXPA03005374 A MX PA03005374A MX PA03005374 A MXPA03005374 A MX PA03005374A MX PA03005374 A MXPA03005374 A MX PA03005374A MX PA03005374 A MXPA03005374 A MX PA03005374A
Authority
MX
Mexico
Prior art keywords
antitumoral
carbazoles
medicament
relates
cotaining
Prior art date
Application number
MXPA03005374A
Other languages
English (en)
Inventor
Garcia Gravalos Dolores
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of MXPA03005374A publication Critical patent/MXPA03005374A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La invencion provee un compuesto de la formula (1): (ver formula) La invencion se refiere a compuestos heterociclicos. Se refiere ademas a metodos para su preparacion, a composiciones que las contienen y a su uso como un medicamento, en particular como un medicamento para el tratamiento y la profilaxis del cancer.
MXPA03005374A 2000-12-13 2001-12-13 Carbazoles antitumorales. MXPA03005374A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0030417.0A GB0030417D0 (en) 2000-12-13 2000-12-13 An anticancer lead compound isolated from a New Zealand ascidian
PCT/GB2001/005523 WO2002048107A1 (en) 2000-12-13 2001-12-13 Antitumoral carbazoles

Publications (1)

Publication Number Publication Date
MXPA03005374A true MXPA03005374A (es) 2004-03-26

Family

ID=9905016

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03005374A MXPA03005374A (es) 2000-12-13 2001-12-13 Carbazoles antitumorales.

Country Status (11)

Country Link
US (1) US7135494B2 (es)
EP (1) EP1349837A1 (es)
JP (1) JP2004518650A (es)
AU (1) AU2002217266A1 (es)
BR (1) BR0116123A (es)
CA (1) CA2431107A1 (es)
GB (1) GB0030417D0 (es)
IL (1) IL156372A0 (es)
MX (1) MXPA03005374A (es)
NZ (1) NZ526399A (es)
WO (1) WO2002048107A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010005870A1 (en) * 2008-07-08 2010-01-14 Trustees Of Dartmouth College Bis-carbazole dna intercalating agents for antitumor therapy
US8530496B2 (en) 2008-07-08 2013-09-10 Trustees Of Dartmouth College Compositions and methods for treating cancer
US8975274B2 (en) 2011-09-20 2015-03-10 Trustees Of Dartmouth College Compositions and methods for treating cancer
CA3077553C (en) 2012-09-25 2022-08-02 Chugai Seiyaku Kabushiki Kaisha Ret inhibitor
MY200583A (en) 2014-04-25 2024-01-04 Chugai Pharmaceutical Co Ltd Formulation containing a large amount of tetracyclic compound
BR112017013982A2 (pt) 2015-01-16 2018-01-02 Chugai Seiyaku Kabushiki Kaisha fármaco de combinação
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
PL3848361T3 (pl) 2018-09-04 2025-07-07 Chugai Seiyaku Kabushiki Kaisha Sposób wytwarzania związku tetracyklicznego
CN119654148A (zh) * 2022-05-09 2025-03-18 癌症研究所(D/B/A福克斯切斯癌症中心研究所) 用于治疗癌症的Curaxin与免疫检查点抑制剂的组合

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0331257A (ja) 1989-06-28 1991-02-12 Kissei Pharmaceut Co Ltd インドール誘導体の製造方法
EP0586608A1 (en) 1991-05-29 1994-03-16 Pfizer Inc. Tricyclic polyhydroxylic tyrosine kinase inhibitors
JPH08157475A (ja) 1994-11-29 1996-06-18 Kissei Pharmaceut Co Ltd １−ヒドロキシインドール誘導体

Also Published As

Publication number Publication date
WO2002048107A1 (en) 2002-06-20
JP2004518650A (ja) 2004-06-24
NZ526399A (en) 2005-02-25
AU2002217266A1 (en) 2002-06-24
GB0030417D0 (en) 2001-01-24
US7135494B2 (en) 2006-11-14
IL156372A0 (en) 2004-01-04
EP1349837A1 (en) 2003-10-08
US20040072890A1 (en) 2004-04-15
CA2431107A1 (en) 2002-06-20
BR0116123A (pt) 2003-10-14

Similar Documents

Publication Publication Date Title
GB0112348D0 (en) Compounds
MXPA03010207A (es) Nuevas 4-anilinoquinolin-3-carboxamidas.
AU2004263179A8 (en) Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
MXPA05011296A (es) Conjugados de fosfonato inhibidores de la cinasa.
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
MXPA03007837A (es) Composiciones para suministrar bisfosfonatos.
DE60112609D1 (en) Pyrazolopyridine
YU84603A (sh) Novi inhibitori tirozin kinaze
GEP20084439B (en) Nitrogen-containing heterocyclic derivatives and pharmaceutical use thereof
AU7743001A (en) Cyclopentanoindoles, compositions containing such compounds and methods of treatment
DE602004021472D1 (en) Pyrimiidinverbindungen
WO2001081310A8 (en) 1-aroyl-piperidinyl benzamidines
MXPA05012025A (es) Imidazo y tiazolopiridinas como inhibidores de cinasa jak3.
MXPA02012033A (es) Derivados de 2-aminocarbonil-9h-purina.
WO2006011050A3 (en) Pyridine derivatives
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
DE60112330D1 (en) Pyrazolopyridinderivate
MY157377A (en) Ophthalmic composition
TWI264437B (en) Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
WO2007052123A3 (en) Pyrazine derivatives as sodium channel modulators for the treatment of pain
MXPA04002042A (es) Compuestos de bencimidazol sustituidos y su uso para el tratamiento del cancer.
MXPA04005809A (es) Inhibidores de proteinas quinasas.
TW200510384A (en) Novel farnesyl protein transferase inhibitors as antitumor agents
MXPA03005374A (es) Carbazoles antitumorales.